Correlation Between Akero Therapeutics and ACADIA Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and ACADIA Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and ACADIA Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akero Therapeutics and ACADIA Pharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and ACADIA Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of ACADIA Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and ACADIA Pharmaceuticals.

Diversification Opportunities for Akero Therapeutics and ACADIA Pharmaceuticals

0.28

Correlation Coefficient

Akero Therapeutics  ACADIA Pharmaceuticals

Modest diversification

The 3 months correlation between Akero and ACADIA is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and ACADIA Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACADIA Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with ACADIA Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACADIA Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and ACADIA Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akero Therapeutics and ACADIA Pharmaceuticals

Given the investment horizon of 90 days Akero Therapeutics is expected to under-perform the ACADIA Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Akero Therapeutics is 1.0 times less risky than ACADIA Pharmaceuticals. The stock trades about -0.16 of its potential returns per unit of risk. The ACADIA Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,637  in ACADIA Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  50.00  from holding ACADIA Pharmaceuticals or generate 3.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Akero Therapeutics  vs.  ACADIA Pharmaceuticals

Akero Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

ACADIA Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ACADIA Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, ACADIA Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Akero Therapeutics and ACADIA Pharmaceuticals

The main advantage of trading using opposite Akero Therapeutics and ACADIA Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, ACADIA Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will offset losses from the drop in ACADIA Pharmaceuticals' long position.

The idea behind Akero Therapeutics and ACADIA Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.